Education
About Us
Working with TipRanks
Follow Us
Machelle Sanders Insider Profile
4 Followers
Machelle Sanders, Director at Novan, holds 40.24K shares in BioCryst (Ticker: BCRX), holds 7.28K shares in Fortrea Holdings Inc. (Ticker: FTRE), holds 25.25K shares in Novan (Ticker: NOVN).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-18.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Machelle Sanders holds in companies
Most Profitable Insider Trade
The most profitable trade made by Machelle Sanders
Machelle Sanders's Trading History
Novan
Jun 27, 2023
Director
Informative Sell
4.62K
―
Radius Health
Aug 15, 2022
―
Uninformative Sell
55.00K
$0.00
BioCryst
Jun 16, 2025
Director
Uninformative Buy
―
$319.92K
Fortrea Holdings Inc.
May 16, 2025
Director
Uninformative Buy
34.81K
$39.76K
List of latest transactions for each holding click on a transaction to see Machelle Sanders's performance on stock
You May Also Like
Machelle Sanders insider profile FAQ
What is the percentage of profitable transactions made by Machelle Sanders?
The percentage of profitable transactions made by Machelle Sanders is 50%.
What is the average return per transaction made by Machelle Sanders?
The average return per transaction made by Machelle Sanders is -18.50%.
What stocks does Machelle Sanders hold?
Machelle Sanders holds: NOVN, ~RDUS, BCRX, FTRE stocks.
What was Machelle Sanders’s latest transaction?
Machelle Sanders latest transaction was an Uninformative Buy of ―.
What was Machelle Sanders's most profitable transaction?
Machelle Sanders’s most profitable transaction was an Informative Sell of BCRX stock on June 15, 2023. The return on the trade was 22.60%.
What is Machelle Sanders's role in Novan?
Machelle Sanders's role in Novan is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.